Three-times weekly teicoplanin in the outpatient treatment of acute methicillin-resistant staphylococcal osteomyelitis: A pilot study

Journal of Chemotherapy

Volumn 14, Issue 1, 2002, Pages 71-75

  Lazzarini, L ^a   Tramarin, A ^a   Bragagnolo, L ^a   Tositti, G ^a   Manfrin, V ^a   De Lalla, F ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Outpatient antibiotic therapy; Staphylococcal osteomyelitis; Teicoplanin

Indexed keywords

TEICOPLANIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OSTEOMYELITIS; OUTPATIENT CARE; STAPHYLOCOCCUS INFECTION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0036197066     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2002.14.1.71     Document Type: Article

References (11)

1. Antimicrobial treatment of chronic osteomyelitis
2. Staging and staging application in osteomyelitis
3. Practice guidelines for community-based anti-infective therapy
4. What's new in exogenous osteomyelitis?
5. Posttraumatic osteomyelitis. Pathophysiology and management
6. Experience with outpatient intravenous teicoplanin therapy for chronic osteomyelitis
7. Management of serious staphylococcal infections in the outpatient setting
8. A risk-benefit assessment of teicoplanin in the treatment of infections
9. Impact of glycopeptide therapy after hospital discharge on inpatients costs: A comparison of teicoplanin and vancomycin
10. Multidrug-resistant gram-positive pathogens: An update on current microbiological patterns